Peer-reviewedCC BY-NC-NDKidney medicine
Drug Dosing in Chronic Kidney Disease: Comparison of Standardized eGFR and eGFR Adjusted for Body Surface Area
- 1Department of Family Medicine & Community Health, Medical School, University of Minnesota, Minneapolis, MN
- 2Department of Pharmaceutical Care & Health Systems, College of Pharmacy, University of Minnesota, Minneapolis, MN
Related
- Next-generation digital polymerase chain reaction assay for BCR::ABL1 in chronic myeloid leukemia: comprehensive validation for standardized measurable residual disease detection
- Lipid-Adjusted Vitamin E Status in Children with Chronic Liver Disease: Reclassification Patterns and Differences According to Cholestasis and Liver Transplantation.
- Comparison of chronic obstructive pulmonary disease awareness across two cross-sectional surveys in Southeastern China from 2019 to 2025
- Survival Outcomes with IL-2-Free Dinutuximab Beta Treatment Strategies With or Without 13-cis-Retinoic Acid in Relapsed or Refractory Neuroblastoma: An Exploratory Unanchored, Population-Adjusted Comparison of Two Prospective Cohorts
- Season-adjusted longitudinal changes in serum 25-hydroxyvitamin D during pegylated interferon add-on to ongoing tenofovir alafenamide therapy in chronic hepatitis B: a real-world cohort study
BibTeX
@article{harris2026drug,
title = {{Drug Dosing in Chronic Kidney Disease: Comparison of Standardized eGFR and eGFR Adjusted for Body Surface Area}},
author = {Ila M. Harris and Ann M. Philbrick},
journal = {Kidney medicine},
year = {2026},
month = sep,
doi = {10.1016/j.xkme.2026.101526},
url = {https://europepmc.org/article/PMC/PMC13722080},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Drug Dosing in Chronic Kidney Disease: Comparison of Standardized eGFR and eGFR Adjusted for Body Surface Area
AU - Ila M. Harris
AU - Ann M. Philbrick
PY - 2026
DA - 2026/09/10
JO - Kidney medicine
DO - 10.1016/j.xkme.2026.101526
UR - https://europepmc.org/article/PMC/PMC13722080
SN - 2590-0595
ER -